# Ultragenyx Pharmaceutical Inc.: Form 4, filed Dec 10, 2020

- Company: [Ultragenyx Pharmaceutical Inc.](/companies/rare.md) (CIK 1515673)
- Form: 4
- Filed: 2020-12-10
- Accepted by EDGAR: Dec 10, 2020, 16:55 ET
- Period: 2020-12-08
- Accession: 0001209191-20-062733
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1515673/000120919120062733/xslF345X03/doc4.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1515673/000120919120062733/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1515673/000120919120062733/xslF345X03/doc4.xml

Filed Dec 10, 2020.
Source: SEC EDGAR, the filing index for accession 0001209191-20-062733. Last ingested by Listed: Nov 3, 2026, 19:02 ET. No prices; not investment advice.